CCL2 and prostate carcinoma: Several other types of cancer cells, including prostate cancer, breast cancer, and myeloma cells, have also been demonstrated to express CCL2 and its receptor CCR2 [19]–[21], both of which are correlated with prostate cancer development [19], [22].